A team from the Harrington Heart and Vascular Institute at University Hospital became the first in the United States to report a safer minimally invasive strategy for eliminating heart infections associated with infective endocarditis on the right side, according to reports Press release from UH.

New strategy- Published in Catheter and Cardiovascular Intervention, From the Journal of the Society for Cardiovascular Angiography and Intervention-Treating infections using the Triever system with FLEX technology, which was originally designed to treat pulmonary embolism, according to a press release.

According to the press release, this novel operation is performed on awake patients in a catheterization laboratory, using intracardiac echocardiography and fluoroscopy guidance, eliminating the need for uncomfortable catheters (transesophageal echocardiography) under the patient’s throat. need.

Download Modern Healthcare’s app to keep up to date when industry news breaks.

Mehdi Shishehbor — Director of the UH Harrington Heart and Vascular Institute and innovative clinicians Angela and James Hambrick — and his team of interventional cardiologists and cardiac surgeons have completed more than a dozen successful cases at UH Cleveland Medical Center.

“The beauty of using Triever technology for this purpose is that it can be done on awake patients. It does not require a heart-lung machine or general anesthesia. The process takes about 20 minutes,” Shishehbor said-he, in a statement provided , Initiated a multi-site registration with his colleagues to further evaluate interventions. “I am optimistic that, given my experience, we can use this new Triever technology in a safer and less intensive way to clear infections. We first provide it to patient candidates who are not good at surgery, we Surprised by its effectiveness.”

According to the press release, this type of heart infection is usually treated with two “less than ideal” surgical and interventional methods: open heart surgery (which is invasive and requires significant recovery) and AngioVac (which requires general anesthesia during the operation) ). Room, and a complete heart-lung machine).

“This is a real revolution in treating these patients,” said Dr. Yasir Abu-Omar, UH’s director of cardiothoracic transplantation and mechanical circulation procedures in a statement. “We no longer need to perform surgery directly. We can try this method first, treat the infection, discharge the patient and receive treatment for substance abuse. If they perform well, no further surgery is needed.” However, if we confirm that they need surgery, we Surgery can be provided after recovery. This is a real paradigm shift. “

This story was originally published by our sister publication, Crane’s Cleveland business.